bioRN News

GA International Inc. is a leading manufacturer of specialty labels, supplying laboratory identification solutions to research laboratories, biobanks, hospitals, and other healthcare institutions. Since its inception, GA International has become a worldwide leader in cryogenic and chemical-resistant labels, strongly dedicated to R&D, product development, and manufacturing. If you would like to learn more, please visit […]

Fundess GmbH is a Munich-based consultancy specializing in funding and financing strategies for R&D projects in life sciences and biotech. It supports startups, growth companies, and research institutions in accessing national and European funding, offering strategic planning, proposal development, and execution support with a focus on innovation and impact. If you would like to learn […]

GliTTher is a German biotech company committed to transforming glioblastoma treatment. Its mission is to develop precision therapies that eliminate the cells driving tumour relapse and resistance. Leveraging a unique platform to identify and target aggressive glioma-initiating cells through their metabolic vulnerabilities and companion diagnostics, GliTTher aims to deliver durable solutions to patients.The company envisions […]

WMT tests substances from the “Translational Trap” platform for antiviral and antisepsis effects in cellular assays and animal models Leipzig and Heidelberg, July 21, 2025 The German Federal Agency for Disruptive Innovations (SPRIN-D) and WMT AG in Heidelberg announced today that SPRIN-D has awarded WMT a research contract. WMT will test selected small molecule active […]

Scientists at Heidelberg University’s Faculty of Medicine have developed new analysis methods for special challenges in tumor diagnostics: One provides important information for the classification of tumors within the limited time frame of brain surgery. The other could use artificial intelligence to improve the accuracy of classification when only a small amount of tumor material […]

With its Proof of Concept grants, the European Research Council (ERC) supports scientists in further developing the economic potential of their research results. Two scientists from the German Cancer Research Center (DKFZ) have now received this coveted funding for the second time: Fabricio Loayza-Puch wants to identify unknown immunoactive peptides on tumor cells that can […]

The protein SNAP-tag is a powerful tool for labeling proteins with synthetic fluorophores for bioimaging. Scientists at the Max Planck Institute for Medical Research in Heidelberg have engineered a much improved version named SNAP-tag2 as well as optimized substrates for faster labeling in live cells. The protein SNAP-tag is a powerful tool for labeling proteins […]

NORTH CHICAGO, Ill. and NEW YORK, July 10, 2025 /PRNewswire/ — AbbVie (NYSE: ABBV) and IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovation, Inc. (IGI), today announced an exclusive licensing agreement for IGI’s lead investigational asset, ISB 2001, developed using IGI’s proprietary BEAT® protein platform, for oncology and autoimmune diseases. “Multispecifics including trispecific antibodies represent a […]

Researchers from Heidelberg and Edinburgh identify a mechanism that balances the genetic disparity between sex chromosomes Birds have developed a unique evolutionary solution to ensure the survival of males – a powerful microRNA. This tiny gene allows male embryos to survive despite a genetic imbalance between the sexes by balancing the activity of the sex […]